India produces a third of the world’s vaccines and accounts for a large generics, biosimilar and NBE & NCE market.
With the global market regaining its confidence in India’s regulatory landscape, there is no better time to expand your business in India.
This event is your prime opportunity to meet with regulators, local pharma representatives and scientists with local expertise as they look to adopt new technologies to accelerate their drug development.
The show will address the new developments and industry challenges faced in the following areas:
BioPharma India will act as a marketplace bringing all elements of the eco system together.
Regulators, local biotechs, global pharmas, IP consultants, manufacturing equipment providers, API and cell line providers and regulatory consultants will come together, allowing India’s biotechs to assess topics such as: drug development, manufacturing and IP protection.
Let us unite.
300+ pharmas and regulators from India, all in one place, all at BioPharma India 2016.
As our partner, you will have the opportunity to: